112 related articles for article (PubMed ID: 23792083)
1. Opportunity to monitor immunosuppressive drugs in peripheral blood mononuclear cells: where are we and where are we going?
Lemaitre F; Antignac M; Verdier MC; Bellissant E; Fernandez C
Pharmacol Res; 2013 Aug; 74():109-12. PubMed ID: 23792083
[TBL] [Abstract][Full Text] [Related]
2. Monitoring of tacrolimus concentrations in peripheral blood mononuclear cells: application to cardiac transplant recipients.
Lemaitre F; Antignac M; Fernandez C
Clin Biochem; 2013 Oct; 46(15):1538-41. PubMed ID: 23454394
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of tacrolimus in liver transplant recipients: inside the white blood cells.
Lemaitre F; Blanchet B; Latournerie M; Antignac M; Houssel-Debry P; Verdier MC; Dermu M; Camus C; Le Priol J; Roussel M; Zheng Y; Fillatre P; Curis E; Bellissant E; Boudjema K; Fernandez C
Clin Biochem; 2015 Apr; 48(6):406-11. PubMed ID: 25562187
[TBL] [Abstract][Full Text] [Related]
4. Intra-cellular immunosuppressive drugs monitoring: A step forward towards better therapeutic efficacy after organ transplantation?
Capron A; Haufroid V; Wallemacq P
Pharmacol Res; 2016 Sep; 111():610-618. PubMed ID: 27468645
[TBL] [Abstract][Full Text] [Related]
5. Effect of immunosuppressive drugs on spontaneous DNA repair in human peripheral blood mononuclear cells.
Ori Y; Herman-Edelstein M; Zingerman B; Rozen-Zvi B; Gafter U; Malachi T; Gafter-Gvili A
Biomed Pharmacother; 2012 Sep; 66(6):409-13. PubMed ID: 22795807
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic monitoring of immunosuppressive drugs: interest of calcineurin activity assessment in liver transplantation].
Blanchet B
Ann Pharm Fr; 2008 Mar; 66(2):96-101. PubMed ID: 18570908
[TBL] [Abstract][Full Text] [Related]
7. Focus on mTOR inhibitors and tacrolimus in renal transplantation: pharmacokinetics, exposure-response relationships, and clinical outcomes.
Shihab F; Christians U; Smith L; Wellen JR; Kaplan B
Transpl Immunol; 2014 Jun; 31(1):22-32. PubMed ID: 24861504
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients.
Fukudo M; Yano I; Masuda S; Fukatsu S; Katsura T; Ogura Y; Oike F; Takada Y; Tanaka K; Inui K
Clin Pharmacol Ther; 2005 Aug; 78(2):168-81. PubMed ID: 16084851
[TBL] [Abstract][Full Text] [Related]
9. Effect of immunosuppressive drugs on DNA repair in human peripheral blood mononuclear cells.
Herman-Edelstein M; Rozen-Zvi B; Zingerman B; Lichtenberg S; Malachi T; Gafter U; Ori Y
Biomed Pharmacother; 2012 Mar; 66(2):111-5. PubMed ID: 22244961
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Drug Monitoring of Everolimus: A Consensus Report.
Shipkova M; Hesselink DA; Holt DW; Billaud EM; van Gelder T; Kunicki PK; Brunet M; Budde K; Barten MJ; De Simone P; Wieland E; López OM; Masuda S; Seger C; Picard N; Oellerich M; Langman LJ; Wallemacq P; Morris RG; Thompson C; Marquet P
Ther Drug Monit; 2016 Apr; 38(2):143-69. PubMed ID: 26982492
[TBL] [Abstract][Full Text] [Related]
11. Effect of different immunosuppressive drugs on immune cells from young and old healthy persons.
Welzl K; Kern G; Mayer G; Weinberger B; Säemann MD; Sturm G; Grubeck-Loebenstein B; Koppelstaetter C
Gerontology; 2014; 60(3):229-38. PubMed ID: 24434865
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic monitoring of mammalian target of rapamycin inhibition by phosphoflow cytometric determination of p70S6 kinase activity.
Hoerning A; Wilde B; Wang J; Tebbe B; Jing L; Wang X; Jian F; Zhu J; Dolff S; Kribben A; Hoyer PF; Witzke O
Transplantation; 2015 Jan; 99(1):210-9. PubMed ID: 25099702
[TBL] [Abstract][Full Text] [Related]
13. Assay validation of phosphorylated S6 ribosomal protein for a pharmacodynamic monitoring of mTOR-inhibitors in peripheral human blood.
Dieterlen MT; Bittner HB; Klein S; von Salisch S; Mittag A; Tárnok A; Dhein S; Mohr FW; Barten MJ
Cytometry B Clin Cytom; 2012 May; 82(3):151-7. PubMed ID: 22213594
[TBL] [Abstract][Full Text] [Related]
14. New concepts to individualize calcineurin inhibitor therapy in renal allograft recipients.
Sommerer C; Giese T; Meuer S; Zeier M
Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1030-7. PubMed ID: 21060169
[TBL] [Abstract][Full Text] [Related]
15. Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial.
Budde K; Becker T; Arns W; Sommerer C; Reinke P; Eisenberger U; Kramer S; Fischer W; Gschaidmeier H; Pietruck F;
Lancet; 2011 Mar; 377(9768):837-47. PubMed ID: 21334736
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolic acid quantification in human peripheral blood mononuclear cells using liquid chromatography-tandem mass spectrometry.
Nguyen Thi MT; Capron A; Mourad M; Wallemacq P
Clin Biochem; 2013 Dec; 46(18):1909-11. PubMed ID: 24060731
[TBL] [Abstract][Full Text] [Related]
17. Measuring Intracellular Concentrations of Calcineurin Inhibitors: Expert Consensus from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Expert Panel.
Lemaitre F; Vethe NT; D'Avolio A; Tron C; Robertsen I; De Winter B; Denicolo A; Koch BCP; Venkataramanan R; Van Gelder T; Brunet M; Bergan S; Hesselink DA; Wallemacq P
Ther Drug Monit; 2020 Oct; 42(5):665-670. PubMed ID: 32520841
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic principles of immunosuppressive drugs.
Budde K; Glander P
Ann Transplant; 2008; 13(3):5-10. PubMed ID: 18806727
[TBL] [Abstract][Full Text] [Related]
19. Everolimus: a proliferation signal inhibitor with clinical applications in organ transplantation, oncology, and cardiology.
Gabardi S; Baroletti SA
Pharmacotherapy; 2010 Oct; 30(10):1044-56. PubMed ID: 20874042
[TBL] [Abstract][Full Text] [Related]
20. Evolution of the therapeutic drug monitoring of cyclosporine.
Citterio F
Transplant Proc; 2004 Mar; 36(2 Suppl):420S-425S. PubMed ID: 15041378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]